“Cisplatin is a life-saving treatment for many children with cancer, but the study published today in Cancer shows that the hearing of very young children is impacted early during treatment and is affected to a greater extent than that of older children.
‘This is significant as even a moderate loss of hearing can impact social development in children, particularly when it occurs during a peak time of language acquisition,’ said the study’s senior author Dr. Bruce Carleton, professor at UBC’s faculty of medicine’s department of pediatrics and an investigator and director of the Pharmaceutical Outcomes Programme at BC Children’s Hospital.
Previous studies have shown up to 60 per cent of children treated with cisplatin suffer from hearing loss and 40 per cent of those children will need hearing aids.”
Learn more on “Chemotherapy drug puts young children with cancer at high risk of hearing loss” via UBC Medicine.
UBC Family Practice Residency Program: Abbotsford-Mission Site 